No deals are currently on the calendar for the week ahead, although some small deals may join the calendar throughout the week, as the typical February lull takes hold of the IPO market while issuers work on year-end audited financials.
While recent IPO jitters may scare some potential issuers, a number of sizable names in the active pipeline are eligible to launch in the week ahead, including fleet management software provider Motive (MTVE), which could raise an estimated $600 million. Other notable names that could set terms include Medtronic’s diabetes carve-out MiniMed Group (MMED), asthma-focused AI biotech Generate Biomedicines (GENB), and crypto investment platform Grayscale (GRAY).
Street research is expected for four companies in the week ahead, and four lock-up periods will be expiring. For access to Street research and lock-up expiration dates, sign up for a free trial of IPO Pro.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 2/19/2026, the Renaissance IPO Index was down 2.0% year-to-date, while the S&P 500 is up 0.4%. Renaissance Capital’s IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include CoreWeave (CRWV) and Kenvue (KVUE). The Renaissance International IPO Index was up 17.6% year-to-date, while the ACWX was up 9.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Kioxia and Galderma.
